Failure path
When local error becomes a shared state.
01Local damage↓
02Error propagation↓
03Common-mode failure↓
04Loss of reserve↓
05Frailty / disease
Breakthrough Lab / Experimental
The place for ideas that may fail.
Breakthrough Lab holds Project 150’s most experimental architectures. Inclusion means an idea is worth testing—not that it is true, safe or ready for a person.
BREAKTHROUGH CANDIDATE / v2.0
DRFC
Distributed Fault‑Containment Process
A speculative control architecture for detecting local faults, limiting their propagation, restoring independent references and verifying function after the intervention ends.
Research hypothesis — not medical advice
DRFC is actuator-agnostic. It does not recommend a drug, dose, device, cell therapy or self-experiment. No human evidence shows that it extends healthspan or lifespan.
Research response
Measure first. Contain before amplification.
01Probe↓
02Map↓
03Contain↓
04Restore references↓
05Asynchronous repair↓
06Verify function
DRFC sequence
Seven gates, no automatic escalation.
Each stage has an uncertainty rule. If the state cannot be observed reliably, the process does not advance.
- 00
Define the adult functional reference
A tissue-specific functional range—not “epigenetic age zero” or the average state of a young animal.
- 01
Probe
Use small, reversible, orthogonal perturbations to measure recovery, overshoot, propagation and uncertainty.
- 02
Map
Identify common modes, propagation hotspots, damaged boundaries and relatively preserved reference regions.
- 03
Contain
Reduce the range of a fault before attempting to amplify repair or growth.
- 04
Restore references
Reactivate or test small, adult, tissue-appropriate reference regions without defaulting to pluripotency.
- 05
Repair asynchronously
Interleave coverage so that independent function and immune surveillance remain active.
- 06
Verify function
After washout, test hard function, a second challenge, clonal ecology, infection competence and pathology.
Architecture audit
Ten ideas entered. Three became finalists.
Two additional architectures were removed as renamed prior art: sequential partial reprogramming and clearance-before-growth as a claimed breakthrough.
Error-covariance architecture
Highest leverage and cleanest matched-burden test; largest risk is that covariance is downstream.
Adult reference microdomains
Most interventional candidate; extensive prior art and the highest oncology burden.
Active controllability tomography
Most feasible measurement concept; useful even if the central aging hypothesis fails.